Proteome Sciences plc (AIM: PRM)

Market Cap	10.51M
Revenue (ttm)	5.03M
Net Income (ttm)	-2.44M
Shares Out	295.18M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,390,780
Open	n/a
Previous Close	3.510
Day's Range	3.560 - 3.560
52-Week Range	3.560 - 7.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathw...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 35
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PRM